Calidi Biotherapeutics Inc. (CLDI) - Cash Funds Calculated per Share

Corporate emblem and logo of Calidi Biotherapeutics Inc. (CLDI)

Outsourcing production to cGMP facilities in the US reduces capital expenditures for Calidi Biotherapeutics (CLDI), and GURU.Markets displays the cash per share level with the current value of 1.21. A team of oncology experts is developing unique platforms, driven by ambitious research. The startup's stability at the pre-commercial stage relies on the success of clinical trials and the procurement of grants, remaining independent of macroeconomic factors.

Calidi Biotherapeutics (CLDI) - Cash per Share from 02/21/2024 to 11/20/2026

Analytical breakdowns for Calidi Biotherapeutics

- cash position and cash flow details:
General company analysis:Calidi Biotherapeutics, Inc., CLDI
Manufactured product of Calidi Biotherapeutics, Inc.

An objective valuation of Calidi Biotherapeutics (CLDI) requires a deep fundamental analysis of liquidity. This metric determines the volume of available cash per common share. By analyzing the change in cash per share, an investor assesses the issuer's ability to fund operating activities. Amid intense competition in the oncolytic virus sector, this reserve is critical for survival. A stable capital level confirms the company's resilience to high scientific risks.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com